S-TARget therapeutics was founded in September 2010 and is funded by Grants from INiTS, AWS and FFG. Furthermore, S-TARget received a PRIMOCID grant from  EUROPRIM-Net under EU contractRII3-026155 of the 6th framework program.

  PRIMOCID